Carbonyl stress and oxidatively modified proteins in chronic renal failure;Stress carbonylé et modifications oxydatives des protéines au cours de l'insuffisance rénale chronique

Annales de Biologie Clinique

Volumn 67, Issue 2, 2009, Pages 153-158

  Bargnoux, A S ^a,b   Morena, M ^b,c   Badiou, S ^a,b   Dupuy, A M ^a   Canaud, B ^a,b,c   Cristol, J P ^a,b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c Institut de Recherche et Formation en Dialyse   (France)

Author keywords

Aopp; Carbonyl stress; Homocysteinrenal insufficiency; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINO ACID; BETA 2 MICROGLOBULIN; REACTIVE OXYGEN METABOLITE;

CHRONIC KIDNEY FAILURE; HUMAN; INFLAMMATION; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN CARBONYLATION; PROTEINURIA; REVIEW; UREMIA;

AMINO ACIDS; BETA 2-MICROGLOBULIN; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEINURIA; REACTIVE OXYGEN SPECIES; UREMIA;

EID: 67549139181     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2009.0295     Document Type: Review

References (42)

1. MorenaM,CristolJP,CanaudB.Whyhemodialysispatientsareinaprooxidantstate? Whatcouldbedone-correctthepro/antioxidantimbalance.BloodPurif2000;18: 191-199(Pubitemid30619958)
2. Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in haemodialysis : beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 1997 ; 12: 2312-2317 (Pubitemid 27474613)
3. Miyata T, Horie K, Ueda Y, et al. Advanced glycation and lipidoxidation of the peritoneal membrane : respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int 2000 ; 58 : 425-435 (Pubitemid 30429891)
4. Handelman GJ, Walter MF, Adhikarla R, et al. Elevated plasma F2isoprostanes in patients on long-term hemodialysis. Kidney Int 2001 ; 59: 1960-1966 (Pubitemid 32336813)
5. Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 2000 ; 58 : 790-799
6. Miyata T, Kurokawa K, Van Ypersele De Strihou C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int 2000 ; 58(Suppl. 76) : 120-125
7. Witko-SarsatV,FriedlanderM,NguyenKhoaT,etal. Advancedoxidationproteinproductsasnovelmediatorsofinflammationandmonocyteactiv ationinchronicrenalfailure.JImmunol1998;161:2524-2532(Pubitemid28397070)
8. Morena M, Delbosc S, Dupuy AM, Canaud B, Cristel JP. Overproduction of reactive oxygen species in end-stage renal disease patients : a potential component of hemodialysis-associated inflammation. Hemodial Int 2005; 9: 37-46. (Pubitemid 40932774)
9. StenvinkelP,HeimbürgerO,LindholmB,KaysenGA,BergströmJ. Aretheretwotypesofmalnutritioninchronicrenalfailure? Evidenceforrelationshipsbetweenmalnutrition, inflammationandatherosclerosis(MIAsyndrome).NephrolDialTransplant2000;15: 953-960(Pubitemid30410364)
10. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia : origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 1999 ; 55 : 389-399
11. Miyazaki H, Matsuoka H, Itabe H, et al. Hemodialysis impairs endothelial function via oxidative stress : effects of vitamin E-coated dialyzer. Circulation 2000; 101:1002-6
12. Chen MF, Chang CL, Liou SY. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif 1998 ; 16 : 290-300.
13. Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 2000 ; 28 : 1717-1725
14. MorenaM,CristolJP,BoseJY,etal. ConvectiveanddiffusivelossesofvitaminCduringhaemodiafiltrationsession: acontributivefactor-oxidativestressinhaemodialysispatients. NephrolDialTransplant2002;17:422-427(Pubitemid34211138)
15. Stadtman ER, Levine RL. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 2003 ; 25: 207-218 (Pubitemid 38043943)
16. Weiss MF, Erhard P, Kader-Attia FA, et al. Mechanisms for the formation of grycoxidation products in end-stage renal disease. Kidney Int 2000; 57: 2571-2585 (Pubitemid 30340756)
17. MiyataT,KurokawaK,VanYperseleDeStrihouC. Advancedglycationandlipoxidationendproducts: roleofreactivecarbonylcompoundsgeneratedduringcarbohydrateandlipidmetabolism. JAmSocNephrol2000;11:1744-1752(Pubitemid30679724)
18. Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 2000; 58: 2571-2578
19. Dursun E, Timur M, Dursun B, Süleymanlar G, Ozben T. Protein oxidation in Type 2 diabetic patients on hemodialysis. J Diabetes Complications 2005 ; 19 : 142-146 (Pubitemid 40615545)
20. Palleschi S, De Angelis S, Diana L, et al. Reliability of oxidative stress biomarkers in hemodialysis patients : a comparative study. Clin Chem Lab Med 2007 ; 45 : 1211-1218 (Pubitemid 47396277)
21. Himmelfarb J, McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 2001 ; 60: 358-363 (Pubitemid 32587575)
22. Mera K, Anraku M, Kitamura K, et al Oxidation and carboxy methyl lysine-modification of albumin : possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res 2005; 28: 973-980 (Pubitemid 43298998)
23. Perla-Kaján J, Twardowski T, Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids 2007 ; 32: 561-572
24. Perna AF, Acanfora F, Luciano MG, et al. Plasma protein homocysteinylation in uremia. Clin Chem Lab Med 2007 ; 45 : 1678-1682
25. Capeillère-Blandin C, Gausson V, Nguyen AT, et al. Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Nephrol Dial Transplant 2006 ; 21: 1555-1563 (Pubitemid 43840618)
26. Valli A, Suliman ME, Meert N, et al. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors. Clin Chim Acta 2007 ; 379: 87-94. (Pubitemid 46366973)
27. Patel RP, Moellering D, Murphy-Ullrich J, Jo H, Beckman JS, Darley-Usmar VM. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic Biol Med 2000 ; 28: 1780-1794 (Pubitemid 30628665)
28. Piroddi M, Depunzio I, Calabrese V, et al. Oxidatively-modified and glycated proteins as candidate pro-inflammatory toxins in uremia and dialysis patients. Amino Acids 2007 ; 32 : 573-592 (Pubitemid 46790939)
29. Witko-Sarsat V, Gausson V, Nguyen AT, et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism : a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 2003; 64: 82-91. (Pubitemid 36714160)
30. Terrier N, Jaussent I, Dupuy AM, et al. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients. Nephrol Dial Transplant 2008 ; 23 : 345-53.
31. Dupuy AM, Jaussent I, Lacroux A, Durant R, Cristol JP, Delcourt C. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome. Gerontology 2007 ; 53 : 329-339
32. Rodriguez-Ayala E, Anderstam B, Suliman ME, et al. Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients. Atherosclerosis 2005 ; 180: 333-340 (Pubitemid 41072904)
33. Yoon YW, Rang TS, Lee BK, et al. Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp Mol Med 2008 ; 40 : 398-406.
34. Dursun B, Dursun E, Suleymanlar G, et al. Carotid artery intimamedia thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis. Nephrol Dial Transplant 2008 ; 23 : 1697-1703 (Pubitemid 351767769)
35. Drüeke T, Witko-Sarsat V, Massy Z, et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002 ; 106: 2212-2217 (Pubitemid 35222215)
36. Zoccali C, Mallamaci F, Asahia K, et al. Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients. J Nephrol 2001 ; 14: 293-8.
37. Kalantar-Zadeh K, Brerman ML, Hazen SL. Serum myeloperoxidase and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2006 ; 48 : 59-68.
38. Taki K, Takayama F, Tsuruta Y, Niwa T. Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int 2006 ; 70: 218-224 (Pubitemid 44000142)
39. Wagner Z, Molnár M, Molnár GA, et al. Serum carboxymethyllysine predicts mortality in hemodialysis patients. Am J Kidney Dis 2006; 47: 294-300. (Pubitemid 43121332)
40. Schwedler SB, Metzger T, Schinzel R, Wanner C. Advanced glycation end products and mortality in hemodialysis patients. Kidney Iit 2002; 62: 301-310 (Pubitemid 34754076)
41. Suliman M, Stenvinkel P, Qureshi AR, et al. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol Dial Transplant 2007 ; 22: 209-217 (Pubitemid 46050347)
42. Antolini F, Valente F, Ricciardi D, Baroni M, Fagugli RM. Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients. Clin Chim Acta 2005 ; 358 : 87-94. (Pubitemid 40966636)